• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    43 Stocks Moving In Tuesday's Mid-Day Session

    3/22/22 12:01:08 PM ET
    $AEI
    $AGTC
    $ALZN
    $AUID
    Real Estate
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AEI alert in real time by email

    Gainers

    • Forge Global Holdings Inc. (NYSE:FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business combination with Motive Capital Corp on the 22nd of March, 2022.
    • Smart for Life, Inc. (NASDAQ:SMFL) rose 26.3% to $1.1750. Trilogy Capital Group LLC's Chairman Alfonso J. Cervantes, Jr. late yesterday disclosed a 29.19% active stake in Smart For Life.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 25.7% to $1.27 after climbing around 10% on Monday.
    • Meiwu Technology Company Limited (NASDAQ:WNW) rose 24.5% to $1.22.
    • HireRight Holdings Corporation (NYSE:HRT) gained 24.3% to $15.59 after the company reported better-than-expected Q4 results. The company also issued FY22 EPS and sales guidance above analyst estimates.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) gained 21.4% to $7.02.
    • FreightCar America, Inc. (NASDAQ:RAIL) surged 19.3% to $5.20 following strong Q4 results.
    • TCR2 Therapeutics Inc. (NASDAQ:TCRR) jumped 18.3% to $3.2550. TCR2 Therapeutics posted a Q4 loss of $0.72 per share.
    • Baozun Inc. (NASDAQ:BZUN) gained 17.6% to $8.13.
    • Bilibili Inc. (NASDAQ:BILI) surged 16.8% to $29.12.
    • Precision BioSciences, Inc. (NASDAQ:DTIL) gained 16.3% to $3.5495. Precision BioSciences Chief Financial Officer John Alexander Kelly acquired a total of 16,677 shares at an average price of $3.08.
    • Dada Nexus Limited (NASDAQ:DADA) surged 15.1% to $10.08.
    • Zhihu Inc. (NYSE:ZH) rose 15% to $2.99 after dipping around 18% on Monday.
    • Gevo, Inc. (NASDAQ:GEVO) shares gained 17.1% to $5.38. Delta Air Lines signed a 75 million gallon per year agreement with Gevo.
    • Pinduoduo Inc. (NASDAQ:PDD) jumped 15% to $45.97. Pinduoduo recently reported Q4 financial results.
    • Alibaba Group Holding Limited (NYSE:BABA) shares rose 13% to $117.09 as the company raised its share buyback program to $25 billion from $15 billion.
    • Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) rose 13% to $1.92. Evolv Technologies recently issued FY22 sales guidance below estimates.
    • Alset EHome International Inc.. (NASDAQ:AEI) rose 12.7% to $0.5398 after surging around 8% on Monday.
    • Alzamend Neuro, Inc. (NASDAQ:ALZN) shares rose 12.6% to $1.2513.
    • Huttig Building Products, Inc. (NASDAQ:HBP) rose 12% to $10.64 after Woodgrain announced plans to acquire the company.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 11.7% to $6.31 after dropping 11% on Monday.
    • Yext, Inc. (NYSE:YEXT) gained 11.4% to $7.34 after the company announced a $100 million buyback.
    • KE Holdings Inc. (NYSE:BEKE) rose 11.4% to $13.54 after dropping more than 14% on Monday.
    • Vroom, Inc. (NASDAQ:VRM) surged 10.2% to $3.02.
    • SuperCom Ltd. (NASDAQ:SPCB) rose 8.6% to $0.7509 after jumping more than 25% on Monday.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 7.3% to $1.3093.
    • Yext, Inc. (NYSE:YEXT) rose 6.8% to $7.04 in pre-market trading after the company announced a buyback. Yext's board approved a share repurchase program, which authorizes the company to repurchase up to $100 million of its common stock.
    • NIKE, Inc. (NYSE:NKE) rose 5.7% to $137.60 in pre-market trading after reporting upbeat quarterly results.


    Losers

    • Statera Biopharma, Inc. (NASDAQ:STAB) shares fell 42.9% to $0.3392 after the company reported pricing of $5.7 million underwritten public offering.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) shares tumbled 31.3% to $4.59 after the company decided to discontinue the further development of ORIC-101 after interim analyses from the two Phase 1b studies, wherein ORIC-101 did not demonstrate sufficient clinical activity. Oppenheimer and Guggenheim downgraded the stock.
    • Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares fell 28.6% to $1.2850 after the company reported pricing of public offering of common stock.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) fell 18% to $5.11. NeuroSense Therapeutics shares jumped around 300% on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
    • Kidpik Corp. (NASDAQ:PIK) fell 17% to $4.81. The company recently reported a partnership with Disney for the release of Cheaper By The Dozen on Disney+.
    • LogicMark, Inc. (NASDAQ:LGMK) dropped 16.3% to $2.4097 after climbing 22% on Monday.
    • FAT Brands Inc. (NASDAQ:FAT) dipped 11.3% to $7.71 following Q4 results.
    • Cyren Ltd. (NASDAQ:CYRN) shares fell 11% to $8.08 after jumping 43% on Monday. Cyren is expected to release its Q4 financial results on Thursday, March 24, 2022, after U.S. markets close.
    • Graphite Bio, Inc. (NASDAQ:GRPH) fell 10.8% to $6.14 after multiple firms lowered their respective price target on the stock following company earnings.
    • Crexendo, Inc. (NASDAQ:CXDO) dipped 10.4% to $3.8999 after the company reported Q4 earnings results.
    • Nkarta, Inc. (NASDAQ:NKTX) dropped 10.3% to $10.35. Nkarta recently posted Q4 loss of $0.69 per share.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) fell 9.6% to $1.60 after jumping around 58% on Monday. Yumanity Therapeutics, last month, announced restructuring plan.
    • CooTek (Cayman) Inc. (NYSE:CTK) fell 8.8% to $0.3008. CooTek (Cayman) recently reported Q4 earnings results.
    • Ipsidy Inc. (NASDAQ:AUID) fell 8.6% to $4.2698. Ipsidy, on Monday, reported FY21 financial results.
    • Hudson Capital Inc. (NASDAQ:HUSN) shares fell 7.6% to $2.43. Hudson Capital shares jumped 27% on Monday after the company reported its Fr8PrivateFleet has already secured new and existing Fr8App customers, including one of Mexico's largest food producers.
    Get the next $AEI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEI
    $AGTC
    $ALZN
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    Nike Inc.
    $NKE
    1/8/2026Hold
    Deutsche Bank
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$200.00 → $180.00Overweight
    Morgan Stanley
    Nike Inc.
    $NKE
    1/8/2026Buy → Hold
    Needham
    Oric Pharmaceuticals Inc.
    $ORIC
    1/7/2026$22.00Overweight
    Piper Sandler
    Nike Inc.
    $NKE
    12/19/2025$75.00 → $72.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $AEI
    $AGTC
    $ALZN
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KE Holdings downgraded by Goldman with a new price target

    Goldman downgraded KE Holdings from Buy to Neutral and set a new price target of $19.00

    2/3/26 6:53:05 AM ET
    $BEKE
    Real Estate
    Finance

    Alibaba upgraded by Arete with a new price target

    Arete upgraded Alibaba from Neutral to Buy and set a new price target of $190.00

    1/21/26 8:25:13 AM ET
    $BABA
    Real Estate

    Deutsche Bank initiated coverage on NIKE

    Deutsche Bank initiated coverage of NIKE with a rating of Hold

    1/8/26 10:59:22 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $AEI
    $AGTC
    $ALZN
    $AUID
    SEC Filings

    View All

    SEC Form PRE 14A filed by Alzamend Neuro Inc.

    PRE 14A - Alzamend Neuro, Inc. (0001677077) (Filer)

    2/9/26 4:30:11 PM ET
    $ALZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.

    6-K - NeuroSense Therapeutics Ltd. (0001875091) (Filer)

    2/9/26 9:30:05 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Zhihu Inc.

    6-K - Zhihu Inc. (0001835724) (Filer)

    2/9/26 7:00:58 AM ET
    $ZH
    Real Estate

    $AEI
    $AGTC
    $ALZN
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

    Strengthens Global IP Portfolio for PrimeC Through 2042 CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the Australian Patent Office (IP Australia) has granted Australian Patent No. 2022370513, entitled "Compositions Comprising Ciprofloxacin and Celecoxib," representing another strategic step in the continued expansion of the Company's global intellectual property protection for PrimeC. The granted Australian patent, following prior approval of the corresponding U.S. patent (12,097,185), further expands 

    2/9/26 9:20:00 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on February 2, 2026 (the "Grant Date"), ORIC granted a total of 173,800 non-qualified stock options and 28,700 restricted stock units to three new non-executive employees who began their employment with ORIC in January 2026. These inducement grants were granted pursuant to the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan, subject to recipient's continued employment or service through each applicable vesting date. Th

    2/6/26 4:30:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will be participating in the following investor conferences in February: Guggenheim Emerging Outlook: Biotech Summit – Participating in a fireside chat on Thursday, February 12, 2026, at 10:30 a.m. ET. Management will also be participating in one-on-one meetings.Citi's 2026 Virtual Oncology Leadership Summit – Participating in a fireside chat on Wednesday, February 18, 2026, at 2:30 p.m. ET. Management will also be participating

    2/5/26 4:01:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEI
    $AGTC
    $ALZN
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Baes Nicholas decreased direct ownership by 5% to 101,023 units (SEC Form 5)

    5 - Bakkt, Inc. (0001820302) (Issuer)

    2/6/26 7:02:42 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Chief Operating Officer Gaylor Douglas Walter

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/6/26 5:31:34 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    SEC Form 4 filed by Chief Executive Officer Korn Jeffrey G

    4 - Crexendo, Inc. (0001075736) (Issuer)

    2/6/26 5:24:15 PM ET
    $CXDO
    Telecommunications Equipment
    Telecommunications

    $AEI
    $AGTC
    $ALZN
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT & CEO Hill Elliott bought $1,001,307 worth of Class B Common Stock (16,388 units at $61.10), increasing direct ownership by 7% to 241,587 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/30/25 4:23:10 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Cook Timothy D bought $2,948,500 worth of Class B Common Stock (50,000 units at $58.97), increasing direct ownership by 90% to 105,480 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/23/25 4:25:32 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Swan Robert Holmes bought $500,080 worth of Class B Common Stock (8,691 units at $57.54), increasing direct ownership by 25% to 43,293 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/23/25 4:21:15 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $AEI
    $AGTC
    $ALZN
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

    TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

    1/20/26 4:05:00 PM ET
    $EVLV
    $TACT
    Computer peripheral equipment
    Technology

    ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

    Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in-class enozertinib Phase 1b data demonstrating highly competitive systemic and intracranial activity in NSCLC patients with EGFR exon 20 and EGFR PACC mutations; selected Phase 3 monotherapy dose Raised $244 million from top-tier healthcare specialist funds; Cash and investments of $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readout for rinzimetostat Phase 3 study Expect to report multiple cli

    1/12/26 8:30:00 AM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bakkt Agrees to Acquire Distributed Technologies Research Ltd.

    - Acquisition advances Bakkt's global stablecoin settlement and programmable payments strategy- Company to operate as "Bakkt, Inc." effective January 22, 2026- Investor Day scheduled for March 17, 2026 at the New York Stock Exchange NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced that it has agreed to acquire Distributed Technologies Research Ltd. ("DTR"), a global stablecoin payment infrastructure provider. Pursuant to the definitive agreement, and as consideration for DTR, Bakkt will issue shares of its Class A common stock representing 31.5% of the "Bakkt Share Number," as defined in the previously announced Coope

    1/12/26 8:00:00 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    $AEI
    $AGTC
    $ALZN
    $AUID
    Financials

    Live finance-specific insights

    View All

    Round Table Pizza Releases February Deals to Fall in Love With

    Heart-Shaped Pizzas and Delicious Deals Worth Celebrating for National Pizza Day and Valentine's Day  LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Round Table Pizza, the pizza franchise owned by FAT Brands Inc. known for its commitment to quality and authenticity, is doubling down on its motto of sharing a little pizza with someone you love with delicious deals for its fans to fall in love with this National Pizza Day (Feb. 9) and Valentine's Day (Feb. 14). Beginning Feb. 7 through Feb. 15 at participating locations, Round Table Pizza will be celebrating its fan-favorite heart-shaped pizzas, offering a Large Heart-Shaped Cheese or Pepperoni Pizza for $19.99. To sweeten the deal even fu

    2/3/26 9:05:00 AM ET
    $FAT
    Restaurants
    Consumer Discretionary

    Johnny Rockets Celebrates Timeless Taste with All-New Hostess® Cupcake Shake

    Burger Chain Becomes First National Restaurant to Debut Beloved Treat in Shake LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Johnny Rockets, the retro, all-American burger concept owned by FAT Brands Inc., is kicking off the new year with a limited-time shake as a nod to classic flavors and timeless taste, the Hostess® Cupcake Shake. In collaboration with Hostess® as well as The Dairy Alliance and Blue Bunny, Johnny Rockets is the first chain to debut the iconic Hostess Cupcake in a shake nationally. Available now through April 30, the Hostess Cupcake Shake combines the beloved flavors of Hostess Cupcakes with an over-the-top creation. Made with creamy chocolate ice cream, a rich swirl

    2/3/26 9:00:00 AM ET
    $FAT
    Restaurants
    Consumer Discretionary

    Evolv Technology to Release Fourth Quarter Financial Results on March 10, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the fourth quarter of 2025 on Tuesday, March 10, 2026, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect potential

    2/2/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $AEI
    $AGTC
    $ALZN
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care